MedTrace Logo

Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers

NCT00613808 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2012-01-25

No results posted yet for this study

Summary

The purpose of this study is to determine whether nitric oxide (NO)gas is effective in the treatment of venous ulcers of the lower leg.

Conditions

  • Venous Ulcers

Interventions

DRUG

Nitric Oxide 200ppm Group B

200 ppm, 8hrs / day for 6 weeks

Sponsors & Collaborators

  • Nitric BioTherapeutics, Inc

    lead INDUSTRY

Principal Investigators

  • Jeffrey Jensen, DPM · Private Practice, Denver, CO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-11-30
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00613808 on ClinicalTrials.gov